TY - JOUR AU - Bedell, S. L. AU - Goldstein, L. S. AU - Goldstein, A. R. AU - Goldstein, A. T. PY - 2020 DA - 2020// TI - Cervical cancer screening: past, present, and future JO - Sex Med Rev VL - 8 UR - https://doi.org/10.1016/j.sxmr.2019.09.005 DO - 10.1016/j.sxmr.2019.09.005 ID - Bedell2020 ER - TY - JOUR AU - Gupta, S. AU - Kumar, P. AU - Das, B. C. PY - 2018 DA - 2018// TI - HPV: molecular pathways and targets JO - Curr Probl Cancer VL - 42 UR - https://doi.org/10.1016/j.currproblcancer.2018.03.003 DO - 10.1016/j.currproblcancer.2018.03.003 ID - Gupta2018 ER - TY - JOUR AU - Estevao, D. AU - Costa, N. R. AU - Gil da Costa, R. M. AU - Medeiros, R. PY - 2019 DA - 2019// TI - Hallmarks of HPV carcinogenesis: the role of E6, E7 and E5 oncoproteins in cellular malignancy JO - Biochim Biophys Acta Gene Regul Mech VL - 1862 UR - https://doi.org/10.1016/j.bbagrm.2019.01.001 DO - 10.1016/j.bbagrm.2019.01.001 ID - Estevao2019 ER - TY - JOUR AU - Song, B. AU - Ding, C. AU - Chen, W. AU - Sun, H. AU - Zhang, M. AU - Chen, W. PY - 2017 DA - 2017// TI - Incidence and mortality of cervical cancer in China, 2013 JO - Chin J Cancer Res VL - 029 UR - https://doi.org/10.21147/j.issn.1000-9604.2017.06.01 DO - 10.21147/j.issn.1000-9604.2017.06.01 ID - Song2017 ER - TY - JOUR AU - Arbyn, M. AU - Weiderpass, E. AU - Bruni, L. AU - Sanjosé, S. AU - Saraiya, M. AU - Ferlay, J. PY - 2020 DA - 2020// TI - Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis JO - Lancet Glob Health VL - 8 UR - https://doi.org/10.1016/S2214-109X(19)30482-6 DO - 10.1016/S2214-109X(19)30482-6 ID - Arbyn2020 ER - TY - JOUR AU - Singh, S. V. AU - Ajay, A. K. AU - Mohammad, N. AU - Malvi, P. AU - Chaube, B. AU - Meena, A. S. PY - 2015 DA - 2015// TI - Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment JO - Cell Death Dis VL - 6 UR - https://doi.org/10.1038/cddis.2015.292 DO - 10.1038/cddis.2015.292 ID - Singh2015 ER - TY - JOUR AU - Barra, F. AU - Lorusso, D. AU - Leone Roberti Maggiore, U. AU - Ditto, A. AU - Bogani, G. AU - Raspagliesi, F. PY - 2017 DA - 2017// TI - Investigational drugs for the treatment of cervical cancer JO - Expert Opin Investig Drugs. VL - 26 UR - https://doi.org/10.1080/13543784.2017.1302427 DO - 10.1080/13543784.2017.1302427 ID - Barra2017 ER - TY - JOUR AU - Marquina, G. AU - Manzano, A. AU - Casado, A. PY - 2018 DA - 2018// TI - Targeted agents in cervical cancer: beyond bevacizumab JO - Curr Oncol Rep VL - 20 UR - https://doi.org/10.1007/s11912-018-0680-3 DO - 10.1007/s11912-018-0680-3 ID - Marquina2018 ER - TY - JOUR AU - Ma, S. AU - Deng, X. AU - Yang, Y. AU - Zhang, Q. AU - Zhou, T. AU - Liu, Z. PY - 2018 DA - 2018// TI - The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/beta-catenin signaling in cervical cancer JO - Biomed Pharmacother VL - 108 UR - https://doi.org/10.1016/j.biopha.2018.10.011 DO - 10.1016/j.biopha.2018.10.011 ID - Ma2018 ER - TY - JOUR AU - Feng, L. L. AU - Shen, F. R. AU - Zhou, J. H. AU - Chen, Y. G. PY - 2019 DA - 2019// TI - Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity JO - Gene VL - 696 UR - https://doi.org/10.1016/j.gene.2019.01.025 DO - 10.1016/j.gene.2019.01.025 ID - Feng2019 ER - TY - JOUR AU - Zhang, D. AU - Sun, G. AU - Zhang, H. AU - Tian, J. AU - Li, Y. PY - 2017 DA - 2017// TI - Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways JO - Biomed Pharmacother VL - 85 UR - https://doi.org/10.1016/j.biopha.2016.11.058 DO - 10.1016/j.biopha.2016.11.058 ID - Zhang2017 ER - TY - JOUR AU - Zhang, J. J. AU - Fan, L. P. PY - 2019 DA - 2019// TI - Long non-coding RNA CRNDE enhances cervical cancer progression by suppressing PUMA expression JO - Biomed Pharmacother VL - 117 UR - https://doi.org/10.1016/j.biopha.2019.108726 DO - 10.1016/j.biopha.2019.108726 ID - Zhang2019 ER - TY - JOUR AU - Yang, W. AU - Xu, X. AU - Hong, L. AU - Wang, Q. AU - Huang, J. AU - Jiang, L. PY - 2019 DA - 2019// TI - Upregulation of lncRNA GAS5 inhibits the growth and metastasis of cervical cancer cells JO - J Cell Physiol VL - 234 UR - https://doi.org/10.1002/jcp.28926 DO - 10.1002/jcp.28926 ID - Yang2019 ER - TY - JOUR AU - Tian, Y. AU - Yu, M. AU - Sun, L. AU - Liu, L. AU - Huo, S. AU - Shang, W. PY - 2019 DA - 2019// TI - Long noncoding RNA00887 reduces the invasion and metastasis of nonsmall cell lung cancer by causing the degradation of miRNAs JO - Oncol Rep VL - 42 ID - Tian2019 ER - TY - JOUR AU - Xie, J. AU - Zhong, Y. AU - Chen, R. AU - Li, G. AU - Luo, Y. AU - Yang, J. PY - 2020 DA - 2020// TI - Serum long non-coding RNA LINC00887 as a potential biomarker for diagnosis of renal cell carcinoma JO - FEBS Open Bio VL - 10 UR - https://doi.org/10.1002/2211-5463.12930 DO - 10.1002/2211-5463.12930 ID - Xie2020 ER - TY - JOUR AU - Yue, W. J. AU - Wang, Y. AU - Li, W. Y. AU - Wang, Z. D. PY - 2020 DA - 2020// TI - LINC00887 regulates the proliferation of nasopharyngeal carcinoma via targeting miRNA-203b-3p to upregulate NUP205 JO - Eur Rev Med Pharmacol Sci VL - 24 ID - Yue2020 ER - TY - JOUR AU - Zuo, J. AU - Yu, H. AU - Xie, P. AU - Liu, W. AU - Wang, K. AU - Ni, H. PY - 2019 DA - 2019// TI - miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma JO - Gene VL - 710 UR - https://doi.org/10.1016/j.gene.2019.06.008 DO - 10.1016/j.gene.2019.06.008 ID - Zuo2019 ER - TY - JOUR AU - Wang, J. PY - 2019 DA - 2019// TI - EP-2161 miR-454-3p regulates cellular radio-sensitivity by targeting to BTG1 in renal carcinoma cells JO - Radiother Oncol VL - 133 UR - https://doi.org/10.1016/S0167-8140(19)32581-2 DO - 10.1016/S0167-8140(19)32581-2 ID - Wang2019 ER - TY - JOUR AU - Song, Y. AU - Guo, Q. AU - Gao, S. AU - Hua, K. PY - 2019 DA - 2019// TI - miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3 JO - Biochem Biophys Res Commun VL - 516 UR - https://doi.org/10.1016/j.bbrc.2019.06.126 DO - 10.1016/j.bbrc.2019.06.126 ID - Song2019 ER - TY - JOUR AU - Torre, L. A. AU - Siegel, R. L. AU - Ward, E. M. PY - 2016 DA - 2016// TI - Global cancer incidence and mortality rates and trends-an update JO - Cancer Epidemiol Biomarkers Prev VL - 25 UR - https://doi.org/10.1158/1055-9965.EPI-15-0578 DO - 10.1158/1055-9965.EPI-15-0578 ID - Torre2016 ER - TY - JOUR AU - Tam, C. AU - Wong, J. H. AU - Tsui, S. K. W. AU - Zuo, T. AU - Chan, T. F. AU - Ng, T. B. PY - 2019 DA - 2019// TI - LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years JO - Appl Microbiol Biotechnol VL - 103 UR - https://doi.org/10.1007/s00253-019-09837-5 DO - 10.1007/s00253-019-09837-5 ID - Tam2019 ER - TY - JOUR AU - Ratti, M. AU - Lampis, A. AU - Ghidini, M. AU - Salati, M. AU - Mirchev, M. B. AU - Valeri, N. AU - Hahne, J. C. PY - 2020 DA - 2020// TI - MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside JO - Target Oncol VL - 15 UR - https://doi.org/10.1007/s11523-020-00717-x DO - 10.1007/s11523-020-00717-x ID - Ratti2020 ER - TY - JOUR AU - Shao, S. AU - Wang, C. AU - Wang, S. AU - Zhang, H. AU - Zhang, Y. PY - 2019 DA - 2019// TI - LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis JO - Biomed Pharmacother VL - 117 UR - https://doi.org/10.1016/j.biopha.2019.109082 DO - 10.1016/j.biopha.2019.109082 ID - Shao2019 ER - TY - JOUR AU - Zhang, G. AU - Wang, Q. AU - Zhang, X. AU - Ding, Z. AU - Liu, R. PY - 2019 DA - 2019// TI - LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis JO - Biomed Pharmacother VL - 118 UR - https://doi.org/10.1016/j.biopha.2019.109309 DO - 10.1016/j.biopha.2019.109309 ID - Zhang2019 ER - TY - JOUR AU - Zhou, J. AU - Lin, J. AU - Zhang, H. AU - Zhu, F. AU - Xie, R. PY - 2018 DA - 2018// TI - LncRNA HAND2-AS1 sponging miR-1275 suppresses colorectal cancer progression by upregulating KLF14 JO - Biochem Biophys Res Commun VL - 503 UR - https://doi.org/10.1016/j.bbrc.2018.07.125 DO - 10.1016/j.bbrc.2018.07.125 ID - Zhou2018 ER - TY - JOUR AU - Katoh, M. PY - 2012 DA - 2012// TI - Function and cancer genomics of FAT family genes (review) JO - Int J Oncol VL - 41 UR - https://doi.org/10.3892/ijo.2012.1669 DO - 10.3892/ijo.2012.1669 ID - Katoh2012 ER - TY - JOUR AU - Xu, Y. AU - Wang, K. AU - Yu, Q. PY - 2016 DA - 2016// TI - FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.12148 DO - 10.18632/oncotarget.12148 ID - Xu2016 ER - TY - JOUR AU - Guan, C. AU - Chang, Z. AU - Gu, X. AU - Liu, R. PY - 2019 DA - 2019// TI - MTA2 promotes HCC progression through repressing FRMD6, a key upstream component of hippo signaling pathway JO - Biochem Biophys Res Commun VL - 515 UR - https://doi.org/10.1016/j.bbrc.2019.05.025 DO - 10.1016/j.bbrc.2019.05.025 ID - Guan2019 ER - TY - JOUR AU - Angus, L. AU - Moleirinho, S. AU - Herron, L. AU - Sinha, A. AU - Zhang, X. AU - Niestrata, M. PY - 2012 DA - 2012// TI - Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.224 DO - 10.1038/onc.2011.224 ID - Angus2012 ER - TY - JOUR AU - Lachenmayer, A. AU - Hoshida, Y. AU - Llovet, J. M. PY - 2010 DA - 2010// TI - Hippo tumor supressor pathway: novel implications for the treatment of hepatocellular carcinoma JO - Gastroenterology VL - 139 UR - https://doi.org/10.1053/j.gastro.2010.06.036 DO - 10.1053/j.gastro.2010.06.036 ID - Lachenmayer2010 ER - TY - JOUR AU - Zheng, Y. AU - Pan, D. PY - 2019 DA - 2019// TI - The Hippo signaling pathway in development and disease JO - Dev Cell VL - 50 UR - https://doi.org/10.1016/j.devcel.2019.06.003 DO - 10.1016/j.devcel.2019.06.003 ID - Zheng2019 ER - TY - JOUR AU - Fodor, L. E. AU - Gezsi, A. AU - Ungvari, L. AU - Semsei, A. F. AU - Gal, Z. AU - Nagy, A. PY - 2017 DA - 2017// TI - Investigation of the possible role of the hippo/YAP1 pathway in asthma and allergy JO - Allergy Asthma Immunol Res VL - 9 UR - https://doi.org/10.4168/aair.2017.9.3.247 DO - 10.4168/aair.2017.9.3.247 ID - Fodor2017 ER - TY - JOUR AU - Zeng, Q. AU - Hong, W. PY - 2008 DA - 2008// TI - The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals JO - Cancer Cell VL - 13 UR - https://doi.org/10.1016/j.ccr.2008.02.011 DO - 10.1016/j.ccr.2008.02.011 ID - Zeng2008 ER - TY - JOUR AU - Zhao, B. AU - Lei, Q. Y. AU - Guan, K. L. PY - 2008 DA - 2008// TI - The Hippo-YAP pathway: new connections between regulation of organ size and cancer JO - Curr Opin Cell Biol VL - 20 UR - https://doi.org/10.1016/j.ceb.2008.10.001 DO - 10.1016/j.ceb.2008.10.001 ID - Zhao2008 ER - TY - JOUR AU - Santos-de-Frutos, K. AU - Segrelles, C. AU - Lorz, C. PY - 2019 DA - 2019// TI - Hippo pathway and YAP signaling alterations in squamous cancer of the head and neck JO - J Clin Med VL - 8 UR - https://doi.org/10.3390/jcm8122131 DO - 10.3390/jcm8122131 ID - Santos-de-Frutos2019 ER -